Processa Pharmaceuticals (PCSA) Current Deferred Tax Assets (2014 - 2016)
Processa Pharmaceuticals' (PCSA) quarterly Current Deferred Tax Assets came in at $5.1 million in Q4 2016, up 2.67% YoY from $4.9 million in Q1 2016, and up 2.67% on a QoQ basis from $4.9 million in Q4 2015.
Processa Pharmaceuticals (PCSA) Current Deferred Tax Assets (2014 - 2016) Analysis & Trends
Processa Pharmaceuticals (PCSA) has 3 years of Current Deferred Tax Assets data on file, last reported at $5.1 million in Q4 2016.
- Quarterly Current Deferred Tax Assets rose 2.67% year-over-year to $5.1 million in Q4 2016, while the trailing twelve-month figure through Dec 2016 was $5.1 million (up 2.67% YoY) and the FY2016 annual result came in at $5.1 million, up 2.67% from the prior year.
- Current Deferred Tax Assets rose to $5.1 million in Q4 2016, from $4.9 million in the prior quarter.
- In the past five years, Current Deferred Tax Assets ranged from a high of $5.1 million in Q4 2016 to a low of $3.4 million in Q4 2014.
- A 3-year average of $4.5 million and a median of $4.9 million in 2015 frame the typical range for Current Deferred Tax Assets.
- Annual changes were most pronounced in 2015 — Current Deferred Tax Assets surged 44.95% — and 2016, when it grew 2.67%.
- Tracing PCSA's Current Deferred Tax Assets over 3 years: stood at $3.4 million in 2014, then jumped by 44.95% to $4.9 million in 2015, then climbed by 2.67% to $5.1 million in 2016.
- The last three Current Deferred Tax Assets figures came in at $5.1 million (Q4 2016), $4.9 million (Q4 2015), and $3.4 million (Q4 2014), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Processa Pharmaceuticals | 5.93 Mn | 5.93 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 5.07 Mn |
| Dec 31, 2016 | 5.07 Mn |
| Dec 31, 2015 | 4.94 Mn |
| Dec 31, 2015 | 4.94 Mn |
| Dec 31, 2014 | 3.41 Mn |
| Dec 31, 2014 | 3.41 Mn |